You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 25, 2024

Patent: 10,000,553


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 10,000,553
Title:CD40L-specific TN3-derived scaffolds and methods of use thereof
Abstract: The present invention provides Tenascin-3 FnIII domain-based scaffolds that specifically bind to CD40L. The invention further provides engineered variants with increased affinity for the target. The present invention is also related to engineered scaffolds as prophylactic, diagnostic, or therapeutic agents, in particular for therapeutic uses against SLE and other autoimmune diseases and conditions.
Inventor(s): Coyle; Anthony (Boston, MA), Baca; Manuel (Gaithersburg, MD), Thisted; Thomas (Gaithersburg, MD), Drabic; Stacey (Gaithersburg, MD), Grinberg; Luba (Gaithersburg, MD), Novarra; Shabazz (Gaithersburg, MD), Oganesyan; Vaheh (Gaithersburg, MD), Herbst; Ronald (Gaithersburg, MD), Spencer; David Kenneth (Gaithersburg, MD)
Assignee: Viela Bio, Inc. (Gaithersburg, MD)
Application Number:14/347,016
Patent Claims:see list of patent claims
Patent landscape, scope, and claims summary:

Understanding the Claims and Patent Landscape of United States Patent 10,000,553

Introduction

When analyzing a patent, particularly one like United States Patent 10,000,553, it is crucial to delve into the specifics of the claims, the patent landscape, and the broader implications of the patent. This article will provide a comprehensive and critical analysis of these aspects.

What is a Patent?

Before diving into the specifics of the patent in question, it's essential to understand what a patent is. A patent is a form of intellectual property that grants the patent holder the exclusive right to make, use, and sell an invention for a specified period, usually 20 years from the filing date of the patent application[3].

Types of Patents

There are several types of patents, including utility patents, design patents, and plant patents. Utility patents, the most common type, are granted for new and useful processes, machines, articles of manufacture, or compositions of matter, or any new and useful improvement thereof[1][3].

The Claims of a Patent

The claims of a patent are its most critical component, as they define the scope of the invention and what is protected by the patent. Each claim must be reviewed to determine which elements or subcombinations are embraced by that claim. Dependent claims often add additional subcombinations or elements to the organization claimed in its parent or independent claim[2].

Analyzing the Claims of United States Patent 10,000,553

To analyze the claims of this patent, one must follow these steps:

Identify the Statutory Categories

Ensure the claimed invention falls within one of the four statutory categories: process, machine, manufacture, or composition of matter. This is crucial as claims that do not fall within these categories are not eligible for patenting[3].

Broadest Reasonable Interpretation (BRI)

Analyze the claim using the broadest reasonable interpretation (BRI) to determine its scope. This involves examining the claim as a whole and considering any additional elements or subcombinations added by dependent claims[3].

Judicial Exceptions

Determine if the claim avoids judicial exceptions such as abstract ideas, natural phenomena, and laws of nature. For example, a process claim must include additional elements that amount to significantly more than the abstract idea itself to be eligible[3].

Patent Landscape and Classification

The patent landscape includes the classification and categorization of patents to facilitate searches and ensure uniform placement.

Classification System

The USPTO uses the United States Patent Classification (USPC) system to classify patents. The primary classification is assigned to the subclass that most typifies the main inventive concept of the application. Secondary classifications are assigned to additional invention information disclosures[2].

Global Dossier and International Searches

For a comprehensive understanding, it is essential to search beyond U.S. patents. Tools like the Global Dossier and databases from international intellectual property offices (such as the European Patent Office, Japan Patent Office, and World Intellectual Property Organization) provide access to related applications and prior art from around the world[4].

The Importance of Prior Art

Prior art is any evidence that your invention is already known. Conducting a thorough prior art search is crucial to ensure the novelty and non-obviousness of the invention.

Conducting a Preliminary Search

Use resources like the Patent Public Search tool, Global Dossier, and international databases to conduct a preliminary search. This helps in identifying existing patents and published patent applications that may be relevant to your invention[4].

Dynamic Drinkware Analysis

When relying on the filing date of a provisional application, it is essential to follow the steps outlined in the Dynamic Drinkware analysis. This involves demonstrating that the provisional application provides a written description that supports the claims of the later patent and that the subject matter relied upon was effectively filed in the provisional application[5].

Case Law and Judicial Precedents

Understanding relevant case law is vital for interpreting the patentability of an invention.

Alice Corp., Myriad, Mayo, and Bilski

Recent Supreme Court decisions such as Alice Corp. v. CLS Bank Int’l, Assoc. for Molecular Pathology v. Myriad Genetics, Inc., Mayo Collaborative Services v. Prometheus Labs. Inc., and Bilski v. Kappos have significantly shaped the landscape of what is eligible for patenting under 35 U.S.C. §101[3].

Practical Implications and Strategies

Protecting Intellectual Property

Receiving a patent, like OxiWear did for their ear-wearable medical device, ensures that the intellectual property of the invention is protected. This protection is crucial for preventing unauthorized use and distribution of the invention[1].

Market Domination

Transforming data into market domination involves leveraging patented inventions to create competitive advantages. By protecting unique processes, machines, or compositions, companies can innovate without fear of imitation, leading to market leadership.

Key Takeaways

  • Claims Analysis: The claims of a patent define its scope and must be carefully analyzed to ensure they fall within statutory categories and avoid judicial exceptions.
  • Patent Landscape: Understanding the broader patent landscape through classification and international searches is essential for ensuring novelty and non-obviousness.
  • Prior Art: Conducting thorough prior art searches using various tools and databases is critical for patent validity.
  • Case Law: Recent judicial precedents significantly influence what is eligible for patenting.
  • Intellectual Property Protection: Patents protect intellectual property, enabling companies to innovate and maintain competitive advantages.

FAQs

Q: What are the four statutory categories of invention under 35 U.S.C. §101? A: The four statutory categories are process, machine, manufacture, and composition of matter[3].

Q: How do you determine the proper classification of a patent application? A: The proper classification is determined by reviewing the claims to identify the main inventive concept and assigning primary and secondary classifications accordingly[2].

Q: What is the significance of the Dynamic Drinkware analysis in patent law? A: The Dynamic Drinkware analysis is crucial for determining if a patent reference is entitled to the filing date of its provisional application, requiring that the provisional application provides a written description supporting the claims and that the subject matter was effectively filed[5].

Q: How can companies use patents to achieve market domination? A: By protecting unique inventions, companies can innovate without fear of imitation, leading to competitive advantages and market leadership.

Q: What resources are available for conducting a preliminary U.S. patent search? A: Resources include the Patent Public Search tool, Global Dossier, international databases, and local Patent and Trademark Resource Centers[4].

Sources

  1. OxiWear Receives Patents from the United States Patent and Trademark Office - OxiWear.
  2. Patent Analysis for Placement into System (Claimed Disclosure) - USPTO.
  3. 35 USC 101: Statutory Requirements and Four Categories of Invention - USPTO.
  4. Search for patents - USPTO - USPTO.
  5. Relying on Provisional Application Filing Date Only Valid When Both Steps of Dynamic Drinkware Analysis Are Proven - Finnegan.

More… ↓

⤷  Subscribe

Details for Patent 10,000,553

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Grifols Therapeutics Llc ALBUKED, PLASBUMIN-20, PLASBUMIN-25, PLASBUMIN-5 albumin (human) For Injection 101138 October 21, 1942 10,000,553 2031-10-11
Takeda Pharmaceuticals U.s.a., Inc. BUMINATE, FLEXBUMIN albumin (human) Injection 101452 March 03, 1954 10,000,553 2031-10-11
Csl Behring Ag ALBURX albumin (human) Injection 102366 July 23, 1976 10,000,553 2031-10-11
Grifols Biologicals Llc ALBUTEIN albumin (human) Injection 102478 August 15, 1978 10,000,553 2031-10-11
Grifols Biologicals Llc ALBUTEIN albumin (human) Injection 102478 November 29, 2022 10,000,553 2031-10-11
Instituto Grifols, S.a. HUMAN ALBUMIN GRIFOLS albumin (human) Injection 103352 February 17, 1995 10,000,553 2031-10-11
Instituto Grifols, S.a. HUMAN ALBUMIN GRIFOLS albumin (human) Injection 103352 June 11, 2003 10,000,553 2031-10-11
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.